Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044753270> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W2044753270 endingPage "386" @default.
- W2044753270 startingPage "385" @default.
- W2044753270 abstract "American Journal of HematologyVolume 81, Issue 5 p. 385-386 Letters and CorrespondenceFree Access Bisphosphonates may potentiate effects of thalidomide–dexamethasone combination in advanced multiple myeloma A. Ugur Ural, A. Ugur Ural Department of Hematology and Medical Research Center, Gulhane Military Medical Academy, Ankara, TurkeySearch for more papers by this authorFerit Avcu, Ferit Avcu Department of Hematology and Medical Research Center, Gulhane Military Medical Academy, Ankara, TurkeySearch for more papers by this author A. Ugur Ural, A. Ugur Ural Department of Hematology and Medical Research Center, Gulhane Military Medical Academy, Ankara, TurkeySearch for more papers by this authorFerit Avcu, Ferit Avcu Department of Hematology and Medical Research Center, Gulhane Military Medical Academy, Ankara, TurkeySearch for more papers by this author First published: 20 April 2006 https://doi.org/10.1002/ajh.20617Citations: 2AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Wang M, Weber DM, Delasalle K, Alexanian R. Thalidomide–dexamethasone as primary therapy for advanced multiple myeloma. Am J Hematol 2005; 79: 194– 197. 2 Ural AU, Avcu F. Evolving therapeutic role of bisphosphonates in multiple myeloma. Br J Cancer 2005; 93: 267– 268. 3 Berenson JR, Hillner BE, Kyle RA, Anderson K, Lipton A, Yee GC. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol 2002; 20: 3719– 3736. 4 Ural AU, Yilmaz MI, Avcu F, Pekel A, Zerman M, Nevruz O, Sengul A, Yalcin A. The bisphosphonate zoledronic acid induces cytotoxicity in human myeloma cell lines with enhancing effects of dexamethasone and thalidomide Int J Hematol 2003; 78: 443– 449. 5 Ural AU, Avcu F. Bisphosphonates may potentiate radiation effects: a new approach in cancer treatment? Biochem Biophys Res Commun 2005; 336: 373– 374. Citing Literature Volume81, Issue5May 2006Pages 385-386 ReferencesRelatedInformation" @default.
- W2044753270 created "2016-06-24" @default.
- W2044753270 creator A5043984651 @default.
- W2044753270 creator A5079748613 @default.
- W2044753270 date "2006-01-01" @default.
- W2044753270 modified "2023-10-14" @default.
- W2044753270 title "Bisphosphonates may potentiate effects of thalidomide–dexamethasone combination in advanced multiple myeloma" @default.
- W2044753270 cites W1972996664 @default.
- W2044753270 cites W1973124455 @default.
- W2044753270 cites W2048999418 @default.
- W2044753270 cites W2074515486 @default.
- W2044753270 cites W2141521877 @default.
- W2044753270 doi "https://doi.org/10.1002/ajh.20617" @default.
- W2044753270 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16628715" @default.
- W2044753270 hasPublicationYear "2006" @default.
- W2044753270 type Work @default.
- W2044753270 sameAs 2044753270 @default.
- W2044753270 citedByCount "3" @default.
- W2044753270 countsByYear W20447532702013 @default.
- W2044753270 crossrefType "journal-article" @default.
- W2044753270 hasAuthorship W2044753270A5043984651 @default.
- W2044753270 hasAuthorship W2044753270A5079748613 @default.
- W2044753270 hasBestOaLocation W20447532701 @default.
- W2044753270 hasConcept C126322002 @default.
- W2044753270 hasConcept C143998085 @default.
- W2044753270 hasConcept C194409129 @default.
- W2044753270 hasConcept C2776364478 @default.
- W2044753270 hasConcept C2779609412 @default.
- W2044753270 hasConcept C2780401358 @default.
- W2044753270 hasConcept C512399662 @default.
- W2044753270 hasConcept C71924100 @default.
- W2044753270 hasConceptScore W2044753270C126322002 @default.
- W2044753270 hasConceptScore W2044753270C143998085 @default.
- W2044753270 hasConceptScore W2044753270C194409129 @default.
- W2044753270 hasConceptScore W2044753270C2776364478 @default.
- W2044753270 hasConceptScore W2044753270C2779609412 @default.
- W2044753270 hasConceptScore W2044753270C2780401358 @default.
- W2044753270 hasConceptScore W2044753270C512399662 @default.
- W2044753270 hasConceptScore W2044753270C71924100 @default.
- W2044753270 hasIssue "5" @default.
- W2044753270 hasLocation W20447532701 @default.
- W2044753270 hasLocation W20447532702 @default.
- W2044753270 hasOpenAccess W2044753270 @default.
- W2044753270 hasPrimaryLocation W20447532701 @default.
- W2044753270 hasRelatedWork W2007073112 @default.
- W2044753270 hasRelatedWork W2010555857 @default.
- W2044753270 hasRelatedWork W2013163224 @default.
- W2044753270 hasRelatedWork W2044994732 @default.
- W2044753270 hasRelatedWork W2085269223 @default.
- W2044753270 hasRelatedWork W2120161314 @default.
- W2044753270 hasRelatedWork W2192430028 @default.
- W2044753270 hasRelatedWork W2356511282 @default.
- W2044753270 hasRelatedWork W2362389383 @default.
- W2044753270 hasRelatedWork W2378175831 @default.
- W2044753270 hasVolume "81" @default.
- W2044753270 isParatext "false" @default.
- W2044753270 isRetracted "false" @default.
- W2044753270 magId "2044753270" @default.
- W2044753270 workType "article" @default.